Submicrometre-sized EuPO 4 hollow spheres: template-directed synthesis and luminescent properties

Micro & nano letters

article

Lihui Zhang¹  Suzhen Bai¹  Hongpeng You²  Huatao Wu¹  Qinlong Peng¹  Weili Li¹  Kesheng Cao¹  Yanbiao Zhou¹ 

[1] School of Chemistry and Environment Engineering, Pingdingshan University;State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 130022 and Graduate University of the Chinese Academy of Sciences

关键词: photoluminescence;    X-ray diffraction;    colloids;    scanning electron microscopy;    transmission electron microscopy;    europium compounds;    submicrometre-sized hollow spheres;    luminescent properties;    colloidal spheres;    X-ray diffraction;    scanning electron microscopy;    transmission electron microscopy;    photoluminescence;    red colour emission;    EuPO4;   

DOI  :  10.1049/mnl.2018.5444

学科分类：计算机科学（综合）

来源: Wiley

【 摘 要 】

Lipid disorders and cardiovascular disease (CVD) risk are known to be increased in patients with diabetes mellitus. The effects of statins on serum lipid levels are well known; however, previous studies did not compare the effects of statins on serum lipid levels in diabetic patients with non-diabetic patients. To investigate the effects of Atorvastatin on serum lipid profiles in hyperlipidemic patients with type 2 diabetes mellitus in comparison with hyperlipidemic patients without diabetes.This study was conducted on 33 type 2 diabetic patients & 34 non-diabetic patients; their age range was 40-80 years, all of them were hyperlipidemic, who had been administered 10, 20, & 40 mg daily of Atorvastatin and completed a 6-month follow-up. Serum lipids were measured before and after treatment at 1, 3, and 6 months.It was found that the reduction in S. Total Cholesterol and S. LDL-C were less in diabetic patients than that in non-diabetic patients when they are using the same doses of Atorvastatin, while the changes in S. HDL-C and S. Triglyceride were nearly similar in both. Furthermore, it is noticed that nearly the same responses of S. Cholesterol and S. LDL-C reduction were achieved in diabetic patients when they are using doubled doses that are used for non-diabetic patients.So,higher doses of Atorvastatin (double doses) are needed to improve serum lipid levels in diabetic patients as compared to non-diabetic patients.

【 授权许可】

CC BY|CC BY-ND|CC BY-NC|CC BY-NC-ND